Lilly Must Divest Sentinel Products After FTC Nod on Novartis Deal

Eli Lilly has won approval to buy Novartis AG's animal health unit on condition that it divests its Sentinel line of products for treating heartworm in dogs, the Federal Trade Commission said on Monday.